article thumbnail

Advanced 3D cell-based technologies

Drug Target Review

Pharmaceutical companies adapted the usage of organoids derived from specific patient derived tumours in cancer drug screening process for testing drug toxicities and efficacy. From 3D cell culture to organs-on-chips. Trends in Cell Biology. Reconstituting Organ-Level Lung Functions on a Chip. 2011;21(12):745-54.

article thumbnail

AM-Pharma Appoints Chief Medical Officer and VP Manufacturing to Support Global Pivotal Trial in Sepsis-associated Acute Kidney Injury

The Pharma Data

a multinational pharmaceutical company, where he was the head of Research & Development and responsible for the R&D strategy (France). in Cell Biology from Utrecht University. Dr. Kraan joins AM-Pharma from Pierre Fabre S.A., Before Pierre Fabre, Dr. Kraan was head of R&D at Stallergenes Greer Ltd.

Trials 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Harini Srinivasan is a Principal Scientific Associate at Serna Bio with over 10 years of research experience in academic institutions, health care organizations and pharmaceutical companies. Driven by an interest in drug discovery Millie joined AstraZeneca after completion of her PhD at the end of 2020.

article thumbnail

Discovering an Antimalarial Drug in Mao’s China

Codon

When Louis Miller, now Chief of Malaria Cell Biology at the NIH, attended a malaria conference in Shanghai in 2008, he asked: Who discovered artemisinin? Medical research groups were joined by pharmaceutical companies, chemical and spice factories, botany institutes, and insect science institutes. Nobody had an answer.

Drugs 129